Korio is a RTSM platform that provides solutions to tackle clinical trial challenges.
Korio has raised $5.5M in total funding. The most recent round was Series A. The last funding was announced in September 2024.
Korio's investors include BIP Ventures, Excelerate Health Ventures, Boston Millennia Partners.
Korio is headquartered in Doylestown, United States.
Korio is a RTSM platform that provides solutions to tackle clinical trial challenges.
Korio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Korio — Funding & Investors." VCBacked, September 10, 2024, https://www.vcbacked.co/company/korio. Accessed July 26, 2026.
VCBacked. (2024). Korio — Funding & Investors. Retrieved July 26, 2026, from https://www.vcbacked.co/company/korio
{{cite web |title=Korio — Funding & Investors |url=https://www.vcbacked.co/company/korio |website=VCBacked |access-date=July 26, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated